跳至主要内容
临床试验/IRCT20150715023218N1
IRCT20150715023218N1招募中1 期

Investigation on Safety and Efficacy of Autologous Human Fibroblasts Transplantation in Regeneration of Atrophic Cutaneous Leishmaniasis Scar.

Iran University of Medical Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 65 years(—)
性别
All

入选标准

  • Ages 15-65
  • Scar lesions caused by Cutaneous leishmaniasis grade 3 to 7;
  • The willingness to provide informed consent for participation in the trial and the ability to communicate with the investigator during follow ups.

排除标准

  • Use of Retinoids in the last 6 months
  • Laser therapy in the last 6 months
  • Cancer or any chronic systemic disease
  • Chemical therapy
  • Mesotherapy
  • Active infection to Leishmaniasis in the scar
  • Oragan or cell transplantation
  • Autoimmune disease
  • Breast feeding
  • Dermal Filler in the last 6 months
  • Plastic surgery at the site of Cutaneous leishmaniasis lesion
  • Use of Corticosteroids
  • Excessive exposure to sun.
  • Subjects who are enrolled in any other clinical trial using systemic medication; or any other treatment that might interfere with this study
  • Subjects with evidence of infection on area to be treated or elsewhere on body.

研究者

相似试验

Fibroblast in Cutaneous Leishmaniasis | 临床试验